RTHP-23. ADJUVANT THERAPY FOR HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA AFTER RTOG 9802: A SURVEY OF CURRENT PRACTICE

PURPOSE: RTOG 9802 long-term results (NEJM, April 2016) demonstrated significant improvements in overall survival with chemoradiotherapy (CRT) compared to radiotherapy alone, for patients with low-grade, high-risk supratentorial oligodendroglioma. Before publication of RTOG 9802, many such patients...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Fakhreddine, Mohamad, Parameswaran, Anand, Floyd, John, Brenner, Andrew, Crownover, Richard
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692294/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.906
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars